E2F Transcription Factor 2 (E2F2)
E2F2 is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein and another 2 members, E2F1 and E2F3, have an additional cyclin binding domain. This protein binds specifically to retinoblastoma protein pRB in a cell-cycle dependent manner, and it exhibits overall 46% amino acid identity to E2F1.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPJ182Hu01 Recombinant E2F Transcription Factor 2 (E2F2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies MAJ182Hu21 Monoclonal Antibody to E2F Transcription Factor 2 (E2F2) WB; IHC; ICC; IP.
PAJ182Hu01 Polyclonal Antibody to E2F Transcription Factor 2 (E2F2) WB; IHC; ICC; IP.
Assay Kits SEJ182Hu ELISA Kit for E2F Transcription Factor 2 (E2F2) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant E2F Transcription Factor 2 (E2F2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to E2F Transcription Factor 2 (E2F2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to E2F Transcription Factor 2 (E2F2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for E2F Transcription Factor 2 (E2F2) CLIA Kit Customized Service Offer
n/a ELISA Kit for E2F Transcription Factor 2 (E2F2) ELISA Kit Customized Service Offer
  1. "Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F."Mol. Cell. Biol. 13:7802-7812(1993) [PubMed] [Europe PMC] [Abstract]
  2. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  3. "The DNA sequence and biological annotation of human chromosome 1." Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release."Cell 123:1093-1106(2005) [PubMed] [Europe PMC] [Abstract]
  6. "EAPP, a novel E2F binding protein that modulates E2F-dependent transcription."Mol. Biol. Cell 16:2181-2190(2005) [PubMed] [Europe PMC] [Abstract]
  7. "Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor."Genes Dev. 16:3199-3212(2002) [PubMed] [Europe PMC] [Abstract]